Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Corrigendum to: Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signalingMolecular oncology, 2022-01, Vol.16 (1), p.307-307 [Periódico revisado por pares]United States: John Wiley & Sons, IncTexto completo disponível |
|
2 |
Material Type: Artigo
|
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapySkoulidis, Ferdinandos ; Heymach, John VNature reviews. Cancer, 2019-09, Vol.19 (9), p.495-509 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
3 |
Material Type: Artigo
|
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trialSubbiah, Vivek ; Cassier, Philippe A ; Siena, Salvatore ; Garralda, Elena ; Paz-Ares, Luis ; Garrido, Pilar ; Nadal, Ernest ; Vuky, Jacqueline ; Lopes, Gilberto ; Kalemkerian, Gregory P ; Bowles, Daniel W ; Seetharam, Mahesh ; Chang, Jianhua ; Zhang, Hui ; Green, Jennifer ; Zalutskaya, Alena ; Schuler, Martin ; Fan, Yun ; Curigliano, GiuseppeNature medicine, 2022-08, Vol.28 (8), p.1640-1645 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
|
4 |
Material Type: Artigo
|
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 PatientsKato, Shumei ; Subbiah, Vivek ; Marchlik, Erica ; Elkin, Sheryl K ; Carter, Jennifer L ; Kurzrock, RazelleClinical cancer research, 2017-04, Vol.23 (8), p.1988-1997 [Periódico revisado por pares]United States: American Association for Cancer Research IncTexto completo disponível |
|
5 |
Material Type: Artigo
|
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancerPopat, Sanjay ; Liu, Stephen V ; Scheuer, Nicolas ; Hsu, Grace G ; Lockhart, Alexandre ; Ramagopalan, Sreeram V ; Griesinger, Frank ; Subbiah, VivekNature communications, 2022-06, Vol.13 (1), p.3500-3500, Article 3500 [Periódico revisado por pares]London: Nature Publishing GroupTexto completo disponível |
|
6 |
Material Type: Artigo
|
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic diseaseWang, Dongdong ; Day, Emily A ; Townsend, Logan K ; Djordjevic, Djordje ; Jørgensen, Sebastian Beck ; Steinberg, Gregory RNature reviews. Endocrinology, 2021-10, Vol.17 (10), p.592-607 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
7 |
Material Type: Artigo
|
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)Huang, Liling ; Jiang, Shiyu ; Shi, YuankaiJournal of hematology and oncology, 2020-10, Vol.13 (1), p.143-143, Article 143 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
Selpercatinib: First ApprovalMarkham, AnthonyDrugs (New York, N.Y.), 2020-07, Vol.80 (11), p.1119-1124 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
9 |
Material Type: Artigo
|
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesDrilon, Alexander ; Hu, Zishuo I ; Lai, Gillianne G Y ; Tan, Daniel S WNature reviews. Clinical oncology, 2018-03, Vol.15 (3), p.151-167 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
10 |
Material Type: Artigo
|
Pralsetinib: First ApprovalMarkham, AnthonyDrugs (New York, N.Y.), 2020-11, Vol.80 (17), p.1865-1870 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |